1381. Publisher Correction: An international perspective on the future of systemic sclerosis research.
作者: David J Abraham.;Carol M Black.;Christopher P Denton.;Jörg H W Distler.;Robyn Domsic.;Carol Feghali-Bostwick.;Pravitt Gourh.;Monique Hinchcliff.;Fred Kolling.;Masataka Kuwana.;Robert Lafyatis.;Ulf Landegren.;J Matthew Mahoney.;Javier Martin.;Marco Matucci-Cerinic.;Zsuzsanna H McMahan.;Ana L Mora.;Luc Mouthon.;Marlene Rabinovitch.;Mauricio Rojas.;Kristofer Rubin.;Maria Trojanowska.;John Varga.;Michael L Whitfield.;Armando Gabrielli.;Thomas Krieg.
来源: Nat Rev Rheumatol. 2025年21卷4期249页 1385. Clinical manifestations, disease penetrance, and treatment in individuals with SOCS1 insufficiency: a registry-based and population-based study.
作者: Jerome Hadjadj.;Anna Wolfers.;Oleg Borisov.;Derek Hazard.;Ronan Leahy.;Marie Jeanpierre.;Alexandre Belot.;Shahrzad Bakhtiar.;Fabian Hauck.;Pui Y Lee.;Stefano Volpi.;Serena Palmeri.;Vincent Barlogis.;Nathalie Aladjidi.;Georg Ebetsberger-Dachs.;Jerome Avouac.;Fabienne Charbit-Henrion.;Morgane Cheminant.;Jean Donadieu.;Sujal Ghosh.;David P Hoytema van Konijnenburg.;Julia Körholz.;Jacinta Bustamante.;Jeremie Rosain.;Lisa Forbes Satter.;Ingrid Selmeryd.;Georgios Sogkas.;Benedicte Neven.;Frederic Rieux-Laucat.;Stephan Ehl.; .
来源: Lancet Rheumatol. 2025年7卷6期e391-e402页
Suppressor of cytokine signalling 1 (SOCS1) insufficiency is an inborn error of immunity affecting the negative regulation of cytokine and growth factor signalling. We aimed to enhance the understanding of clinical manifestations, disease trajectories, disease penetrance, and the effect of Janus kinase (JAK) inhibition in individuals with SOCS1 insufficiency.
1388. Is thickened hyaline cartilage on ultrasound a sign of osteoarthritis? A within-person, between-joint pilot study.
作者: Edoardo Cipolletta.;Gianluca Smerilli.;Riccardo Mirza Mashadi.;Peter Mandl.;Emilio Filippucci.
来源: BMC Rheumatol. 2025年9卷1期24页
To determine whether the presence of conventional radiography (CR)-detected osteophytes is associated with focal thickening of the hyaline cartilage by ultrasound (US) in the same area of the metacarpal head in a within-person, between-joint cross-sectional comparison in patients with hand osteoarthritis (HOA).
1389. A cohort study in HigAshi-nippon of Pulmonary hyPertensIoN in systEmic SclerosiS (HAPPINESS study): protocol and baseline data for an observational study.
作者: Shuhei Takeyama.;Hironari Hanaoka.;Akiyoshi Hashimoto.;Yusho Ishii.;Yuka Shimizu.;Toshiharu Takeuchi.;Shuhei Shimoyama.;Masataka Kuwana.;Tomoaki Higuchi.;Masaru Yoshimura.;Hiroshi Kataoka.;Yuko Shirota.;Kazufumi Okada.;Yoichi M Ito.;Ryo Hisada.;Kazuro Kamada.;Sho Ishigaki.;Tetsuya Horita.;Tatsuya Atsumi.;Masaru Kato.; .
来源: BMC Rheumatol. 2025年9卷1期25页
Pulmonary hypertension (PH) is the leading cause of death among patients with systemic sclerosis (SSc). Recently, early therapeutic intervention to improve the prognosis was suggested, and the definition of PH was recently revised by lowering the cut-off value of mean pulmonary arterial pressure (mPAP) from ≥ 25 to > 20 mmHg. However, the optimal threshold for therapeutic intervention remains unclear. We aim to evaluate the prognosis of patients with SSc and its relationship with mPAP.
1390. Exploring the influence of social support, disease activity, and fibromyalgia on the emotional well-being of women with systemic lupus erythematosus.
作者: Fatima Alnaimat.;Omar Hamdan.;Tala Natsheh.;Raghad Bani Hamad.;Zain Abu Amrieh.;Dania Ahmad.;Mahdi H Mohammed.;Nada Al-Awamleh.
来源: BMC Rheumatol. 2025年9卷1期26页
Systemic Lupus erythematosus (SLE) is an autoimmune disorder in which females are affected more commonly than males. In addition to the physical burden of the disease, patients with SLE are at higher risk of psychological disorders. In Jordan, there is a paucity of studies assessing the emotional well-being and psychosocial burden of SLE. This study aims to explore fibromyalgia, mental health-related problems and their association with SLE disease activity and its various manifestations.
1391. Neoplasm related mortality risk in Systemic Sclerosis: a nationwide study.
作者: María Martínez-Urbistondo.;Antonio González-Guzmán.;Román Fernández-Guitián.;Xiomara Patricia Blanco-Valencia.;Jorge Esteban-Sampedro.;Mario Martín-Portugués.;Pedro Durán-Del Campo.;Pablo Tutor.;Susana Mellor-Pita.;Alfonso Ortega-de la Puente.;Marina de la Cruz-Echeandía.;Víctor Moreno-Torres.
来源: BMC Rheumatol. 2025年9卷1期27页
The higher mortality rates in patients with Systemic sclerosis (SSc) are related to SSc activity, cardiovascular disease, and neoplasms, among other factors. Our objective was to assess the impact of solid organ neoplasms (SON) and hematological neoplasms (HN) on mortality among SSc patients.
1394. Prevalence and clinical significance of anti-neutrophil cytoplasmic antibodies in interstitial lung disease: a retrospective cohort study.
作者: Tingting Wu.;Chao Cao.;Zekai Cen.;Haijun Zhou.;Dan Lv.;Yun Zhang.;Qunli Ding.
来源: Rheumatology (Oxford). 2025年64卷SI期SI105-SI113页
Antineutrophil cytoplasmic antibodies (ANCAs) are occasionally positive in patients with interstitial lung disease (ILD). The positivity rates of ANCAs in various types of ILD and the role of ANCAs in ILD are still unclear. The purpose of this study was to estimate the prevalence of ANCAs in Chinese people diagnosed with ILD (including idiopathic pulmonary fibrosis) and identify differences in clinical features, radiographic features and survival between patients with ANCA-positive and ANCA-negative ILD.
1395. Treatment guidelines for idiopathic inflammatory myopathies in adults: a comparative review.
作者: Julie J Paik.;Victoria P Werth.;Hector Chinoy.;Karim R Masri.;Amruta Jambekar.;Feza Hasan.;Cecilia E Borlenghi.;David A Gold.
来源: Rheumatology (Oxford). 2025年64卷6期3288-3302页
Myositis, or idiopathic inflammatory myopathy, encompasses a group of autoimmune diseases with broad-spectrum clinical presentations, with a common presentation of muscle weakness and inflammation. The management of myositis presents significant challenges due to the rarity and variability of the disease and lack of large-scale, randomized controlled trials. Due to limited evidence available from smaller studies as well as variation in treatment practices across geographical regions and disease subtypes, available published treatment recommendations vary significantly. There is a need, therefore, to develop multidisciplinary consensus-driven guidelines that appropriately reflect the diverse and complex nature of the disease. This comparative review presents an in-depth analysis of existing myositis treatment guidelines from diverse organizations, highlighting similarities and key differences in diagnoses, treatment and management recommendations. We propose that there is a need for developing globally unified, consensus-driven standardized set of guidelines for effective myositis management.
1396. Patient reported physical function, mental health, and treatment patterns in dermatomyositis: survey results from a cross-sectional study of adult dermatomyositis patients.
作者: Lisa Christopher-Stine.;Julie J Paik.;Alexandra S Goriounova.;Paul N Mudd.
来源: BMC Rheumatol. 2025年9卷1期23页
Dermatomyositis (DM) is a rare and progressive immune-mediated disease with no cure and significant patient burden that encompasses physical, mental, and financial impacts. Patients experience debilitating symptoms that may include muscle weakness, itchy and painful rash, joint pain, and fatigue. Despite the heterogeneity of the disease and the breadth of possible symptoms, the impact of DM on a diverse range of patients' quality of life (QoL) has not been well-characterized in literature. The aim of this study was to describe the experiences of patients living with DM as they relate to physical and mental impacts, productivity, and treatment patterns and satisfaction.
1397. The impact of anti-TNF-α therapy on leptin and inflammatory markers in rheumatoid arthritis patients: a case-control study.
作者: Mostafa Kaboli.;Manouchehr Nakhjavani.;Soghra Rabizadeh.;Marsa Gholamzadeh.;Seyed Reza Najafizadeh.
来源: BMC Rheumatol. 2025年9卷1期22页
Rheumatoid arthritis (RA) is a systemic autoimmune disease characterized by synovial inflammation, cartilage, and bone destruction. Several studies have shown that leptin plays an important role in the pathophysiology of RA disease. This study aimed to evaluate serum levels of leptin in RA patients receiving biologic drugs compared to RA patients managed by non-biologic drugs, and healthy individuals.
1400. Abatacept and the risk of malignancy: a meta-analysis across disease indications.
作者: Benjamin P Zuckerman.;Mark Gibson.;Ritika Roy.;Mark Hughes.;Daksh Mehta.;Zijing Yang.;Maryam Adas.;Kenrick Ng.;Mark D Russell.;Andrew Cope.;Sam Norton.;James Galloway.
来源: Rheumatology (Oxford). 2025年64卷6期3280-3287页
To estimate the association between abatacept use and the incidence of malignancy excluding non-melanomatous skin cancers (NMSCs).
|